Sbi healthcare opportunities fund nav
WebApr 13, 2024 · SBI Healthcare Opportunities Fund - Regular Plan - Growth Regular Direct Category : Sectoral/Thematic Fund House : SBI Mutual Fund NAV : ₹ 217.2349 0.61% (as … Invest in high-rated bonds from as low as Rs. 10,000. Find & Invest in bonds issued … WebApr 11, 2024 · Invest in high-rated bonds from as low as Rs. 10,000 Find & Invest in bonds issued by top corporates, PSU Banks, NBFCs, and much more. Invest as low as 10,000 and earn better returns than FD ...
Sbi healthcare opportunities fund nav
Did you know?
WebApr 13, 2024 · SBI Healthcare Opportunities Fund - Direct Plan Value Research Analyst’s Choice Riskometer Very High Value Research Rating Unrated 3 Year 25.20% NAV-Growth … WebFeb 28, 2024 · SBI Healthcare Opportunities Fund is benchmarked against S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index. The NAV of SBI Healthcare Opportunities Fund ended down ₹-1.91 (-0.89%) yesterday to ₹213.0595 .
WebApr 10, 2024 · SBI Healthcare Opportunities-G Fund Category Sectoral / Thematic Very High Equity G NAV ( 10 Apr 2024) ₹ 218.3 1M Returns 6.66% Compare Funds Performance 1M 3M 6M 1Y 3Y 5Y MAX 24.04 % 3y Returns 0.49% 1D Returns Investment details Min SIP amount ₹ 500 Min Lumpsum ₹ 5000 Lock In 0 Expense ratio 2.2% Exit load WebApr 13, 2024 · ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan Value Research Analyst’s Choice Riskometer Very High Value Research Rating Unrated 3 Year 25.04% NAV-Growth ₹19.1800 -0.16% As on 20-Mar-2024 Overview Return Premium Coverage Risk Portfolio Peer Comparison Fund News Other Returns The underlying data …
WebHistorical Mutual Fund NAV of SBI HEALTHCARE Opportunities Reg Gr Select Start Date Select End Date Submit Download Result entries Showing 1 to 25 of 229 entries Previous 1 2 3 4 5 … 10 Next Advisorkhoj develops innovative mutual fund research tools and Calculators that may help you in your investments.
WebApr 11, 2024 · This fund has been in existence for 4 yrs 9 m, having been launched on 11/06/2024. Mirae Asset Healthcare Fund Direct - Growth has ₹1,505 Crores worth of assets under management (AUM) as on 31/12/2024 and is medium-sized fund of its category. The fund has an expense ratio of 0.52%, which is less than what most other …
Web8 hours ago · Latest SBI MCLR The overnight MCLR rate is 7.90%, while that of one month tenure is 8.10%. ... mutual funds for FY 2024-24 (AY 2024-25) 2 New ... Lakh Crore Gone 10 Factors Why Sensex Is Down 2400 Points In 7 Days India Likely To Miss 2030 Deadline For Over Half Of Health Sdgs Lancet Study A Second Half Stock Market Rally Is Still In Play ... find the stickmen ice cave codeWebAlso known as SBI Healthcare Opportunities Fund, this fund is aiming to provide growth and consistent returns to its investors. SBI Pharma Fund is a mutual fund scheme intended for investors who are looking for opportunities to invest in pharmaceutical sector and companies thereby. erika costell free shipping hoodieWebMar 28, 2024 · SBI Healthcare Opportunities Fund-Growth Unrated ADD TO PORTFOLIO NAV as on 28 Mar 2024 213.5673 -0.09 (-0.04%) Factsheet Investment Objective The scheme … erika costell shaved back hairWebJun 10, 2024 · The top 5 holdings are in Sun Pharmaceutical Inds. Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Ltd. SBI Healthcare Opportunities Fund's NAV as of June 9, 2024, is ... find the stickman yellow buttonsWebCurrent Funding Opportunities. Research funding schemes currently open for applications. ... National Health and Medical Research (NHMRC) & Medical Research Future Fund … erika costell sweatshirtWebApr 13, 2024 · SBI Healthcare Opportunities Fund - Direct Plan Value Research Analyst’s Choice Riskometer Very High Value Research Rating Unrated 3 Year 25.20% NAV-Growth ₹240.0350 -0.14% As on 17-Mar-2024 Overview Return Premium Coverage Risk Portfolio Peer Comparison Fund News Other Returns The underlying data is unavailable. erika crossland obituary uniontown paWebSBI Healthcare Opportunities Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 13.4% over a period of 18 years. The … erika costell there for you